| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 07/27/1999 | US5929122 Combination preparation containing tramadol and a calcium channel antagonist |
| 07/27/1999 | US5929120 Guainidino, formamidino, amino and related compounds for inhibiting osteoclast-mediated bone resorption |
| 07/27/1999 | US5929112 Use in pharmaceuticals or cosmetics as antioxidants, improved bioavailability |
| 07/27/1999 | US5929089 Antiserotonine agent |
| 07/27/1999 | US5929067 N-acylating amine derivative of caprolactam compound with a carboxylic acid or derivatives to form amide derivative of caprolactam compound |
| 07/27/1999 | US5929065 Adminsitering a patient suffering from sleep disorder a hypnotically effective amount of 4,5,6,7-tetrahydroisoxaxole(5,4-c)pyridine-3-ol(thip) |
| 07/27/1999 | US5929063 Mercapto and seleno derivatives as inhibitors of nitric oxide synthase |
| 07/27/1999 | US5929061 Method for treating vascular headaches |
| 07/27/1999 | US5929056 Accesible from readily available starting materials to be used for wound healing and in cosmetics |
| 07/27/1999 | US5929046 Pyrimidine and purine derivatives and their use in treating tumour cells |
| 07/27/1999 | US5929045 Screening for bactericides |
| 07/27/1999 | US5929040 Method for the prophylaxis and/or treatment of proliferative and/or inflammatory skin disorders |
| 07/27/1999 | US5929032 Method for treating Schwann and colon cells in vitro |
| 07/27/1999 | US5929029 Human calcium-binding phosphoprotein |
| 07/27/1999 | US5928939 Genetic engineering |
| 07/27/1999 | US5928938 Isolated peptides which complex with HLA-Cw*16 molecules, and uses thereof |
| 07/27/1999 | US5928899 Cell division regulators |
| 07/27/1999 | US5928876 Peptide and collagen contraction inhibitor |
| 07/27/1999 | US5928654 Modulating body/cranial hair growth with lipoxygenase/cyclooxygenase inhibitors |
| 07/27/1999 | US5928649 Administering interleukin or inducer concurrently with vaccine to swine or cattle |
| 07/27/1999 | US5928636 Injecting synergistic mixture to treat herpes, hepatitis, papilloma and human t-cell leukemia/lymphoma viruses; administering as bactericide, parasiticide, and/or antiprotozoa agent |
| 07/27/1999 | CA2170700C Pyrazolopyrimidines and pyrrolopyrimidines for treatment of neuronal and other disorders |
| 07/27/1999 | CA2166721C Bicyclic tetrahydro pyrazolopyridines |
| 07/27/1999 | CA2164804C Nk-1 receptor antagonists for the treatment of neuronal injury and stroke |
| 07/27/1999 | CA2155837C Benzopyrans as potassium channel openers |
| 07/27/1999 | CA2025663C Indole derivatives |
| 07/27/1999 | CA2016504C Process and intermediates for the preparation of oxophthalazinyl acetic acids and analogs thereof |
| 07/22/1999 | WO1999036570A2 Transglutaminase linkage of agents to tissue |
| 07/22/1999 | WO1999036541A1 INTERLEUKIN-1 RECEPTOR ANTAGONIST BETA (IL-1RAβ) |
| 07/22/1999 | WO1999036535A1 Apo-2 ligand |
| 07/22/1999 | WO1999036531A1 Gtpase derived from human lymph nodes that effects the morphology and cytoskeleton organization of endothelial cells |
| 07/22/1999 | WO1999036512A1 Secreted proteins and polynucleotides encoding them |
| 07/22/1999 | WO1999036439A1 Polypeptides, dna coding therefor, formulations thereof, and their use in inhibiting factor xii activation |
| 07/22/1999 | WO1999036438A1 HUMAN CMRF-35-H9 RECEPTOR WHICH BINDS IgM |
| 07/22/1999 | WO1999036436A1 FATTY ACID SYNTHASE mRNA BINDING PROTEIN |
| 07/22/1999 | WO1999036431A1 Compounds with growth hormone releasing properties |
| 07/22/1999 | WO1999036426A1 N-[2-(5-BENZYLOXYCARBONYL-AMINO-6-OXO-2-(4-FLUOROPHENYL)-1,6-DIHYDRO-1-PYRIMIDINYL)ACETO- XYL]-L-ASPARTIC ACID ALDEHYDE AS AN IN VIVO INHIBITOR OF INTERLEUKIN-1β CONVERTING ENZYME (ICE) |
| 07/22/1999 | WO1999036425A1 Platelet adp receptor inhibitors |
| 07/22/1999 | WO1999036424A1 Piperazino derivatives as neurokinin antagonists |
| 07/22/1999 | WO1999036423A1 Triazolo-pyridazine derivatives as ligands for gaba receptors |
| 07/22/1999 | WO1999036422A1 Methods of synthesizing and screening inhibitors of bacterial nad synthetase enzyme, compounds thereof, and methods of treating bacterial and microbial infections with inhibitors of bacterial nad synthetase enzyme |
| 07/22/1999 | WO1999036421A1 4-(2-keto-1-benzimidazolinyl)piperidine compounds as orl1-receptor agonists |
| 07/22/1999 | WO1999036420A1 Thiophene nitrone compounds |
| 07/22/1999 | WO1999036418A1 Substituted bicyclic lactones |
| 07/22/1999 | WO1999036417A1 SUBSTITUTED β,η-ANELLATED LACTONES |
| 07/22/1999 | WO1999036416A1 SUBSTITUTED α,β-ANELLATED BUTYROLACTONES |
| 07/22/1999 | WO1999036415A1 Thioether furan nitrone compounds |
| 07/22/1999 | WO1999036409A1 Metabolically inert anti-inflammatory and anti-tumor antifolates |
| 07/22/1999 | WO1999036407A1 Novel allylthiopyridazine derivatives and process for preparing the same |
| 07/22/1999 | WO1999036404A1 Bisulfate salt of hiv protease inhibitor |
| 07/22/1999 | WO1999036398A1 Aminosulphonylbenzamide derivatives as modulators of the activity of neuronal calcium channels |
| 07/22/1999 | WO1999036396A1 Triazepinones, process for their preparation and their therapeutic application |
| 07/22/1999 | WO1999036393A1 INHIBITORS OF α4 MEDIATED CELL ADHESION |
| 07/22/1999 | WO1999036392A1 Novel tricyclic compounds, preparation method and pharmaceutical compositions containing same |
| 07/22/1999 | WO1999036384A1 Alkenyldiarylmethane non-nucleoside hiv-1 reverse transcriptase inhibitors |
| 07/22/1999 | WO1999036096A1 Pharmaceutical formulations and processes for their preparation |
| 07/22/1999 | WO1999036093A1 Methods of using human receptor protein 4-1bb |
| 07/22/1999 | WO1999036091A2 Method for inhibiting cd95-independent apoptosis in aids |
| 07/22/1999 | WO1999036077A1 Composition and method for treatment and prevention of arthritis and/or autoimmune diseases |
| 07/22/1999 | WO1999036076A1 Composition containing propargylamine for enhancing cancer therapy |
| 07/22/1999 | WO1999036070A1 Il-8 receptor antagonists |
| 07/22/1999 | WO1999036069A1 Il-8 receptor antagonists |
| 07/22/1999 | WO1999036064A2 Methods of treating tardive dyskinesia and other movement disorders |
| 07/22/1999 | WO1999036044A1 Mixture for the oxidation tinting of keratin fibres containing a laccase and tinting method using said mixture |
| 07/22/1999 | WO1999030157A3 Neuropilins in methods for diagnosis and prognosis of cancer |
| 07/22/1999 | WO1999026632B1 Phospholipids having antimicrobial activity with or without the presence of antimicrobials |
| 07/22/1999 | WO1999025690A3 Advanced glycation end-product intermediaries and post-amadori inhibition |
| 07/22/1999 | WO1999024042A3 Stable antiandrogenic gel composition |
| 07/22/1999 | WO1999012971A3 Amino acid sequences for therapeutical and prophylactic applications to diseases due to clostridium difficile toxins |
| 07/22/1999 | WO1998059040A3 Human catalytic telomerase sub-unit and its diagnostic and therapeutic use |
| 07/22/1999 | WO1998055495B1 Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof |
| 07/22/1999 | DE19801647A1 New beta, gamma-fused lactone glutamate receptor modulators for treating cerebral ischemia, cranial or brain trauma, pain or CNS-mediated spasms |
| 07/22/1999 | DE19801646A1 New bicyclic lactone glutamate receptor modulators for treating cerebral ischemia, cranial/brain trauma, pain or CNS-mediated spasms |
| 07/22/1999 | DE19801636A1 New bi:cyclic lactone glutamate receptor modulators |
| 07/22/1999 | CA2319063A1 Il-8 receptor antagonists |
| 07/22/1999 | CA2318693A1 Composition containing propargylamine for enhancing cancer therapy |
| 07/22/1999 | CA2318661A1 Transglutaminase linkage of agents to tissue |
| 07/22/1999 | CA2318558A1 Compounds with growth hormone releasing properties |
| 07/22/1999 | CA2318555A1 Thiophene nitrone compounds |
| 07/22/1999 | CA2318525A1 Methods of using human receptor protein 4-1bb |
| 07/22/1999 | CA2318358A1 Polypeptides, dna coding therefor, formulations thereof, and their use in inhibiting factor xii activation |
| 07/22/1999 | CA2318357A1 Thioether furan nitrone compounds |
| 07/22/1999 | CA2318199A1 Platelet adp receptor inhibitors |
| 07/22/1999 | CA2318195A1 Il-8 receptor antagonists |
| 07/22/1999 | CA2317944A1 Mixture for the oxidation tinting of keratin fibres containing a laccase and tinting method using said mixture |
| 07/22/1999 | CA2317942A1 Alkenyldiarylmethane non-nucleoside hiv-1 reverse transcriptase inhibitors |
| 07/22/1999 | CA2317813A1 Composition and method for treatment and prevention of arthritis and/or autoimmune diseases |
| 07/22/1999 | CA2317760A1 Piperazino derivatives as neurokinin antagonists |
| 07/22/1999 | CA2317536A1 Aminosulphonylbenzamide derivatives as modulators of the activity of neuronal calcium channels |
| 07/22/1999 | CA2317439A1 Methods of synthesizing and screening inhibitors of bacterial nad synthetase enzyme, compounds thereof, and methods of treating bacterial and microbial infections with inhibitors of bacterial nad synthetase enzyme |
| 07/22/1999 | CA2317392A1 Secreted proteins and polynucleotides encoding them |
| 07/22/1999 | CA2315299A1 Fatty acid synthase mrna binding protein |
| 07/22/1999 | CA2315219A1 Triazolo-pyridazine derivatives as ligands for gaba receptors |
| 07/22/1999 | CA2314148A1 Pharmaceutical formulations and processes for their preparation |
| 07/22/1999 | CA2309546A1 N-[2-(5-benzyloxycarbonyl-amino-6-oxo-2-(4-fluorophenyl)-1,6-dihydro-1-pyrimidinyl)acetoxyl]-l-aspartic acid aldehyde as an in vivo inhibitor of interleukin-1.beta. converting enzyme (ice) |
| 07/21/1999 | EP0930302A2 Benzosulfone derivatives |
| 07/21/1999 | EP0930076A1 Medicinal compositions |
| 07/21/1999 | EP0930075A1 Methods for preventing, inhibiting or treating graft rejection reactions in graft-versus-host disease (gvhd) and organ transplantation |
| 07/21/1999 | EP0930067A2 Mmp inhibitors for the treatment of ocular angiogenesis |
| 07/21/1999 | EP0929674A2 HUMAN Bad POLYPEPTIDES, ENCODING NUCLEIC ACIDS AND METHODS OF USE |